Rankings
▼
Calendar
FLGT FY 2018 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$447M
FY 2018 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$21M
+14.0% YoY
Gross Profit
$11M
49.9% margin
Operating Income
-$5M
-23.7% margin
Net Income
-$6M
-26.3% margin
EPS (Diluted)
$-0.25
Cash Flow
Operating Cash Flow
-$675,000
Free Cash Flow
-$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$55M
Total Liabilities
$3M
Stockholders' Equity
$52M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$19M
+14.0%
Gross Profit
$11M
$10M
+4.8%
Operating Income
-$5M
-$3M
-45.6%
Net Income
-$6M
-$3M
-123.4%
← Q4 2017
All Quarters
Q1 2018 →